Open AccessCluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with <i>nucleophosmin1</i>-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin
Author(s) -
Katrin Teich,
Julia Krzykalla,
Silke Kapp-Schwoerer,
Verena I. Gaidzik,
Richard F. Schlenk,
Peter Paschka,
Daniela Weber,
Walter Fiedler,
Michael W.M. Kühn,
Thomas Schroeder,
Karin Mayer,
Michael Lübbert,
Dhanya Ramachandran,
Axel Benner,
Arnold Ganser,
Hartmut Döhner,
Michael Heuser,
Konstanze Döhner,
Felicitas Thol
Publication year - 2021
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.278894
Subject(s) - gemtuzumab ozogamicin , myeloid leukemia , single nucleotide polymorphism , medicine , hematology , cancer research , immunology , genetics , genotype , biology , cd33 , gene , stem cell , cd34
Not available.